Literature DB >> 14700756

[Tachycardia-induced cardiomyopathy in children: a difficult diagnosis but a reversible form of left ventricular dysfunction].

M El Hajjar1, J S Hermida, F M Caron, D Nassif, E Bourges-Petit, Y Maingourd.   

Abstract

UNLABELLED: Tachycardia-induced cardiomyopathy is a reversible left ventricular dysfunction caused by cardiac arrhythmia. Because of its reversibility, a correct diagnosis and treatment are necessary. The aim of our study was to precise the diagnostic procedures of the tachycardia-induced cardiomyopathy and to study the left ventricular function after the correction of the arrhythmia. PATIENTS AND METHODS: A retrospective study done between 1992 and 2001. Children studied were followed-up for: an idiopathic form of cardiomyopathy, in which the etiological research showed a cardiac arrhythmia; a cardiac arrhythmia associated to a cardiomyopathy. An electrocardiogram recorded the cardiac arrhythmia. The left ventricular function was evaluated by an echocardiography before and every month after the correction of the cardiac arrhythmia.
RESULTS: Twelve children were included, ages ranged from 2 months to 15 years (median 11 years). Four patients presented a cardiac insufficiency associated to arrhythmia; three followed-up for an arrhythmia developed a cardiomyopathy; five whose cardiac arrhythmia was not easy to demonstrate had an idiopathic form of cardiomyopathy. The Wilcoxon test showed a significant amelioration (P < 0.01) of the left ventricular function after the correction of the cardiac arrhythmia.
CONCLUSIONS: Tachycardia-induced cardiomyopathy in children is curable and the diagnosis is quite difficult. Pediatricians and family doctors should try to look for specific signs of cardiac insufficiency or arrhythmia. Pediatric cardiologists should search a tachycardia-induced cardiomyopathy in every idiopathic form of cardiomyopathy.

Entities:  

Mesh:

Year:  2004        PMID: 14700756     DOI: 10.1016/j.arcped.2003.11.005

Source DB:  PubMed          Journal:  Arch Pediatr        ISSN: 0929-693X            Impact factor:   1.180


  4 in total

1.  Stimulants and cardiovascular events in youth with attention-deficit/hyperactivity disorder.

Authors:  Mark Olfson; Cecilia Huang; Tobias Gerhard; Almut G Winterstein; Stephen Crystal; Paul D Allison; Steven C Marcus
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  2011-12-20       Impact factor: 8.829

Review 2.  Cardiovascular safety of stimulants in children: findings from recent population-based cohort studies.

Authors:  Almut G Winterstein
Journal:  Curr Psychiatry Rep       Date:  2013-08       Impact factor: 5.285

3.  Cardiovascular safety of central nervous system stimulants in children and adolescents: population based cohort study.

Authors:  Almut G Winterstein; Tobias Gerhard; Paul Kubilis; Arwa Saidi; Stephan Linden; Stephen Crystal; Julie Zito; Jonathan J Shuster; Mark Olfson
Journal:  BMJ       Date:  2012-07-18

4.  [Poorly tolerated broad QRS complex tachycardia in a newborn].

Authors:  Désiré Alain Affangla; Mohamed Leye; Angèle Wabo Simo; Franck D'Almeida; Thérèse Yandé Sarr; Adamson Phiri; Adama Kane
Journal:  Pan Afr Med J       Date:  2017-06-30
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.